# Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer

> **NCT02070120** · PHASE2 · UNKNOWN · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 82 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Mitomycin C
- **PROCEDURE:** Surgical Management

## Key facts

- **NCT ID:** NCT02070120
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2018-01
- **Final completion:** 2020-09
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2020-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02070120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02070120, "Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02070120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*